Dapavo, P., Megna, M., & Talamonti, M. (2024). Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate to severe plaque psoriasis. Dermatology Reports. https://doi.org/10.4081/dr.2024.9999